Related Experiment Video

Updated: Jan 17, 2026

SUMO-Binding Entities SUBEs as Tools for the Enrichment, Isolation, Identification, and Characterization of the SUMO Proteome in Liver Cancer
08:29

SUMO-Binding Entities SUBEs as Tools for the Enrichment, Isolation, Identification, and Characterization of the SUMO Proteome in Liver Cancer

Published on: November 1, 2019

7.6K

Research advancements on sumoylation in gastrointestinal cancers

Xiang Li1, Rui Ding2, Hui Wang2

  • 1Department of Gastroenterology, Yan'an Hospital Affiliated to Kunming Medical University, Kunming, Yunnan, 650051, China; Kunming Medical University, Kunming, Yunnan, 650500, China.

Molecular Aspects of Medicine
|September 13, 2025
PubMed

Insights

SUMOylation, a key protein modification, drives cancer growth and treatment resistance in gastrointestinal cancers. Targeting SUMOylation pathways offers a promising strategy for developing novel anticancer therapies.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • SUMOylation is a crucial post-translational modification regulating protein function via SUMO protein attachment.
  • This process involves E1, E2, E3 ligases, and deSUMOylation enzymes, controlling vital cellular processes.
  • SUMOylation dysregulation is implicated in cancer initiation and therapeutic resistance.

Purpose of the Study:

  • To elucidate the role of SUMOylation in oncogenesis, particularly in gastrointestinal malignancies.
  • To explore SUMOylation's contribution to tumor aggressiveness, metastasis, and treatment resistance.
  • To highlight SUMOylation as a potential target for novel anticancer drug development.

Main Methods:

  • Literature review and analysis of existing research on SUMOylation.
  • Examination of SUMOylation's impact on protein activity, stability, and cellular localization.
  • Investigation of SUMOylation's role in gene expression, cell cycle, DNA repair, and metabolic pathways.

Main Results:

  • SUMOylation dysregulation promotes tumor cell motility, aggressiveness, and epithelial-mesenchymal transition (EMT).
  • In gastrointestinal cancers, SUMOylation fuels tumor growth, metastasis, and invasiveness by altering metabolic and signaling networks.
  • SUMOylation contributes to resistance against chemotherapy and radiotherapy.

Conclusions:

  • Understanding SUMOylation's molecular mechanisms is vital for comprehending its role in cancer.
  • Targeting SUMOylation pathways presents a promising avenue for developing innovative cancer treatments.
  • Further research into SUMOylation could lead to more effective therapies for gastrointestinal malignancies.
Keywords:
Gastrointestinal cancersSUMOylationSignal transductionTranscriptional regulation

More Related Videos

In Vivo Detection and Analysis of Rb Protein SUMOylation in Human Cells09:40

In Vivo Detection and Analysis of Rb Protein SUMOylation in Human Cells

Published on: November 2, 2017

7.7K
In Vitro SUMOylation Assay to Study SUMO E3 Ligase Activity09:45

In Vitro SUMOylation Assay to Study SUMO E3 Ligase Activity

Published on: January 29, 2018

9.7K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.9K